Author's posts
Progress In Tissue Engineering: Controlling Cell-Cell Signaling
A recent study reveals the potential of harnessing cell to cell communication to advance tissue engineering.
Emergence Of IgG4 In Long-Term Vaccines: Winning Or Losing The Race?
An uncommon type of antibody is on the rise after multiple vaccinations or infections. Here we discuss what this could mean.
More Than A Gut Feeling
The pleasure of eating begins in the mouth, albeit extends far beyond it. From the first bite to the moment that waste is released, the brain is receiving signals from olfactory and gustatory receptors throughout the digestive system.
You Can Now Control A Wheelchair With Your Brain Waves Alone
A completely non-invasive technology allows people to control a wheelchair simply by using their minds and a cap that decodes their brain waves.
Viral Sleight Of Hand: SARS-CoV-2 Mimics Host Protein, Regulates Gene Expression
SARS-CoV-2 is a master of deception, capable of evading and suppressing our immune system in multiple ways. New research describes a previously unknown strategy: mimicry of histone proteins, which help regulate gene expression.
Respiratory Viruses Sensitive To Mild Acidification Of Ambient Air
A new Swiss study has discovered that certain levels of acidity can inactivate different viruses, providing a new tool to control airborne transmission.
Synthetic Gene Circuit To Hone CAR T Therapy
A study published in Science demonstrates how synthetic gene circuits could improve CAR T therapy’s precision and efficacy.
African Morgue Data Reveals A More Significant Covid-19 Death Toll Than Official Reporting
A new study led by Boston University School of Public Health researchers suggests that the reported Covid-19 death toll in Africa is substantially higher than official records indicate.
How Recently Approved Tocilizumab Treats Covid-19
The FDA recently approved the drug Tocilizumab for use in hospitalized adults with severe Covid. Here we take a closer look at the data behind the approval.
New Monoclonal Antibody Fully Approved For The Treatment Of Covid-19
The Food and Drug Administration has approved Tocilizumab for use against moderate to severe Covid-19 symptoms.
